Joseph P. Lucia & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-251
Closed -$23K 312
2022
Q2
$23K Sell
251
-50
-17% -$4.43K 0.02% 238
2022
Q1
$25K Buy
+301
New +$23.7K 0.02% 244
2021
Q4
Sell
-351
Closed -$26K 390
2021
Q3
$26K Hold
351
0.02% 277
2021
Q2
$27K Sell
351
-17
-5% -$1.26K 0.02% 282
2021
Q1
$27K Hold
368
0.01% 267
2020
Q4
$29K Buy
+368
New +$28.1K 0.02% 231
2020
Q3
Sell
-420
Closed -$31K 315
2020
Q2
$31K Hold
420
0.03% 205
2020
Q1
$31K Sell
420
-26
-6% -$2.04K 0.03% 195
2019
Q4
$39K Buy
446
+104
+30% +$8.54K 0.04% 196
2019
Q3
$27K Hold
342
0.03% 221
2019
Q2
$27K Sell
342
-27,313
-99% -$2.09M 0.03% 221
2019
Q1
$326 Buy
+27,655
New +$2.07M 0.02% 189

Other funds holding MRK

Joseph P. Lucia & Associates's MRK Position: Q3 2022 in Review

Joseph P. Lucia & Associates sold out of Merck (MRK) in Q3 2022, closing a stake of 251 shares — an estimated $23K sold.

Joseph P. Lucia & Associates first reported a position in MRK in Q1 2019 and held it in 12 quarters. The position peaked at $39K in Q4 2019. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Joseph P. Lucia & Associates reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 251 Merck shares in Q3 2022, an estimated $23K.
  • Joseph P. Lucia & Associates first reported a position in Merck in Q1 2019 and held it in 12 quarters.
  • Joseph P. Lucia & Associates's Merck position peaked at $39K in Q4 2019.
  • 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Joseph P. Lucia & Associates's 13F filing for Q3 2022, filed 28 Oct 2022.